• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

European Commission

Sanofi
Pharma

Sanofi offers commitments to end EU flu shot antitrust probe

Amid an EU probe into whether Sanofi “disparaged” one of its flu vaccine rivals, the French pharma has proposed several marketing changes.
Fraiser Kansteiner Jul 8, 2026 4:26pm
Sanofi

EC begins antitrust probe into Sanofi's flu shot campaign

Jun 26, 2026 11:20am
Vaccines business

Biovac nets $108M finance package for integrated vaccine plant

Apr 20, 2026 9:31am
Roches headquarters in Basel sunset in the background

Roche seeks partner to take over plant, produce key antibiotic

Feb 20, 2026 10:30am
drugs 2025 2025 in pharma regulatory tracker pharma 2025

Regulatory tracker: Rubraca scores full prostate cancer approval

Dec 18, 2025 2:45pm
An artists 3D rendering of cancerous blood cells among healthy red blood cells The cells fill the image and are of various

ExCellThera's blood cancer cell therapy Zemcelpro earns EU nod

Aug 27, 2025 7:40am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings